Sargent Investment Group’s VIVEVE MED INC VIVE Stock Holding History

Sargent Investment Group’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10	Closed	-$4K	–	155
2019 Q2	$4K	Buy	+10	New	+$5.42K	﹤0.01%	143
2019 Q1	–	Sell	-30	Closed	-$32K	–	136
2018 Q4	$32K	Buy	+30	New	+$72K	0.02%	125

Other funds holding VIVE

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sargent Investment Group's VIVE Position: Q3 2019 in Review

Sargent Investment Group sold out of VIVEVE MED INC (VIVE) in Q3 2019, closing a stake of 10 shares — an estimated $4K sold.

Sargent Investment Group first reported a position in VIVE in Q4 2018 and held it in 2 quarters. The position peaked at $32K in Q4 2018. 11 funds tracked by Wall St. Rank hold VIVE as of Q3 2019.

Sargent Investment Group reported no remaining VIVEVE MED INC position as of Q3 2019 after selling out during the quarter.
Sargent Investment Group sold 10 VIVEVE MED INC shares in Q3 2019, an estimated $4K.
Sargent Investment Group first reported a position in VIVEVE MED INC in Q4 2018 and held it in 2 quarters.
Sargent Investment Group's VIVEVE MED INC position peaked at $32K in Q4 2018.
11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2019.

Based on Sargent Investment Group's 13F filing for Q3 2019, filed 29 Oct 2019.